Synonym
SKF-10047; SKF10047; SKF 10047; N-Allylnormetazocine hydrochloride; N Allylnormetazocine hydrochloride; NANM;
IUPAC/Chemical Name
(2α,6α)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-propenyl)-2,6-methano-3-benzazocin-8-ol Hydrochloride
InChi Key
ZTGMHFIGNYXMJV-BZJVTDFFSA-N
InChi Code
InChI=1S/C17H23NO.ClH/c1-4-8-18-9-7-17(3)12(2)16(18)10-13-5-6-14(19)11-15(13)17;/h4-6,11-12,16,19H,1,7-10H2,2-3H3;1H/t12-,16-,17-;/m0./s1
SMILES Code
OC1=CC=C2C([C@@]3(C)CCN(CC=C)[C@@]([C@@H]3C)([H])C2)=C1.[H]Cl
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
293.84
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Herling S, Woods JH. Discriminative stimulus effects of etorphine in Rhesus monkeys. Psychopharmacology (Berl). 1981;72(3):265-7. doi: 10.1007/BF00431828. PMID: 6784144.
2: Iwamoto ET. Pharmacologic effects of N-allylnormetazocine (SKF-10047). NIDA Res Monogr. 1981 Feb;34:82-8. PMID: 6783955.
3: Wood PL, Rackham A. Actions of kappa, sigma and partial mu narcotic receptor agonists on rat brain acetylcholine turnover. Neurosci Lett. 1981 Apr 9;23(1):75-80. doi: 10.1016/0304-3940(81)90190-7. PMID: 6262686.
4: Chang KJ, Hazum E, Cuatrecasas P. Novel opiate binding sites selective for benzomorphan drugs. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4141-5. doi: 10.1073/pnas.78.7.4141. PMID: 6270660; PMCID: PMC319744.
5: Itzhak Y, Kalir A, Sarne Y. On the opioid nature of phencyclidine and its 3-hydroxy derivative. Eur J Pharmacol. 1981 Jul 17;73(2-3):229-33. doi: 10.1016/0014-2999(81)90097-2. PMID: 6273187.
6: Su TP. Psychotomimetic opioid binding: specific binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. Eur J Pharmacol. 1981 Oct 15;75(1):81-2. doi: 10.1016/0014-2999(81)90352-6. PMID: 6274661.
7: Holtzman SG. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey. Psychopharmacology (Berl). 1982;77(4):295-300. doi: 10.1007/BF00432758. PMID: 6813889.
8: Pfeiffer A, Herz A. Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique. Mol Pharmacol. 1982 Mar;21(2):266-71. PMID: 6124875.
9: Ouyang A, Clain CJ, Snape WJ Jr, Cohen S. Characterization of opiate-mediated responses of the feline ileum and ileocecal sphincter. J Clin Invest. 1982 Mar;69(3):507-15. doi: 10.1172/jci110476. PMID: 6277992; PMCID: PMC371006.
10: Hampton RY, Medzihradsky F, Woods JH, Dahlstrom PJ. Stereospecific binding of 3H-phencyclidine in brain membranes. Life Sci. 1982 Jun 21;30(25):2147-54. doi: 10.1016/0024-3205(82)90288-0. PMID: 7109842.
11: Johnson KM, Hillman GR. Comparisons between phencyclidine, its monohydroxylated metabolites, and the stereoisomers of N-allyl-N-normetazocine (SKF 10047) as inhibitors of the muscarinic receptor and acetylcholinesterase. J Pharm Pharmacol. 1982 Jul;34(7):462-4. doi: 10.1111/j.2042-7158.1982.tb04761.x. PMID: 6126548.
12: Tung AS, Yaksh TL. In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord. Brain Res. 1982 Sep 9;247(1):75-83. doi: 10.1016/0006-8993(82)91029-0. PMID: 6127147.
13: Zukin SR. Differing stereospecificities distinguish opiate receptor subtypes. Life Sci. 1982 Sep 20-27;31(12-13):1307-10. doi: 10.1016/0024-3205(82)90368-x. PMID: 6292619.
14: Su TP. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther. 1982 Nov;223(2):284-90. PMID: 6290634.
15: Inoki R, Kim SY, Maeda S, Nakamae J, Mashimo T, Yoshiya I. Effect of inhalational anesthetics on the opioid receptors in the rat brain. Life Sci. 1983;33 Suppl 1:223-6. doi: 10.1016/0024-3205(83)90483-6. PMID: 6319866.
16: Pilapil C, Wood PL. [3H]-SKF 10047 binding to rat brain membranes: evidence for kappa isoreceptors. Life Sci. 1983;33 Suppl 1:263-5. doi: 10.1016/0024-3205(83)90493-9. PMID: 6319874.
17: West RE Jr, McLawhon RW, Dawson G, Miller RJ. [3H]ethylketocyclazocine binding to NCB-20 hybrid neurotumor cells. Mol Pharmacol. 1983 Mar;23(2):486-92. PMID: 6339880.
18: Johnson N, Pasternak GW. The binding to rat brain homogenates of Mr2034, a universal opiate. Life Sci. 1983 Sep 5;33(10):985-91. doi: 10.1016/0024-3205(83)90755-5. PMID: 6310291.
19: Stafford I, Tomie A, Wagner GC. Effects of SKF-10047 in the phencyclidine- dependent rat: evidence for common receptor mechanisms. Drug Alcohol Depend. 1983 Oct;12(2):151-6. doi: 10.1016/0376-8716(83)90039-x. PMID: 6317323.
20: Tang AH, Code RA. Discriminative stimulus properties of nalorphine in the rhesus monkeys. J Pharmacol Exp Ther. 1983 Dec;227(3):563-9. PMID: 6317838.
